Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 945.00
+8.30 (0.89%)
Nov 7, 2025, 3:29 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 942.54 billion as of November 7, 2025. Its market cap has decreased by -8.24% in one year.
Market Cap
942.54B
Enterprise Value
996.09B
Revenue
244.94B
Ranking
n/a
PE Ratio
19.16
Stock Price
945.00
Market Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 942.54B, an increase of 11,400.29%. That is a compound annual growth rate of 22.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 942.54B | -3.60% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | 488.07B | 87.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.81T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.13T |
| Mankind Pharma | 978.03B |
| Fortis Healthcare | 769.38B |
| Alkem Laboratories | 672.97B |
| Aurobindo Pharma | 667.40B |